Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin, Carbetocin, and Misoprostol for PPH Prevention in Elective CS
NCT02053922Phase 3
Key facts
- Status
- Completed
- Start
- Dec 2012
- Primary completion
- Aug 2013
- Countries
- 1
- Sponsor
- Ain Shams University
- Modality
- Small Molecules
- Drugs
- misoprostol
- Conditions
- postpartum hemorrhage (PPH)
01
Overview
Phase 3, randomised, single-blind trial of misoprostol in postpartum hemorrhage (PPH), sponsored by Ain Shams University. Started Dec 2012; status: completed.
02
Design
- Study design
- RandomizedSingle-blind
03
Who it enrols
Pregnant women (GA >= 37 weeks) undergoing elective Cesarean section under regional anesthesia with a transverse lower segment incision, excluding those with high-risk conditions like HELLP, eclampsia, or significant organ disease.
04
Registry description
The use of Oxytocin, Carbetocin and buccal misoprostol in patients undergoing elective Cesarean Section
Beyond the preview
Go deeper on NCT02053922.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02053922.